Award
National Cancer Institute 5R01CA297601-02
Systematic Testing of a TGF Targeted Theranostic in Preclinical Cancer
Recipient
Not specified
Award Amount
$676,179.00
Ceiling
$676,179.00
Awarded
December 17, 2025
Identifier
5R01CA297601-02
Award for research on TGF targeted theranostic in cancer models to evaluate pharmacokinetics, dosimetry, and radiation response mechanisms, funded by NIH/NCI.
Description
The project involves testing a theranostic targeting TGF activity in multiple cancer models. The project aims to evaluate pharmacokinetics, dosimetry, and cellular mechanisms of radiation response. The project is funded by the NIH/NCI under grant number 5R01CA297601-02. The project duration is from December 16, 2024, to November 30, 2029.